Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients

被引:1
|
作者
Peng, Qi [1 ]
Huang, Shujun [2 ]
Chen, Xiaoying [3 ]
Yuan, Yayan [2 ]
Yu, Yajun [2 ]
Tao, Liang [1 ]
Zhang, Zhenlu [4 ]
Xu, Mousheng [2 ]
机构
[1] Wuhan Asia Heart Hosp, Cardiac Surg, Wuhan 430022, Hubei, Peoples R China
[2] Hubei Vidagen Gene Technol Co Ltd, Wuhan 430075, Hubei, Peoples R China
[3] Wuhan Asia Heart Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China
[4] Wuhan Asia Heart Hosp, Clin Test Ctr, Wuhan 430022, Hubei, Peoples R China
关键词
algorithm; Chinese; clinical accuracy; dose; pharmacogenetics; warfarin; HEART-VALVE REPLACEMENT; DOSE REQUIREMENTS; DOSING ALGORITHM; COMPARATIVE PERFORMANCE; MULTIETHNIC POPULATION; ATRIAL-FIBRILLATION; CYP2C9; GENOTYPES; BODY-WEIGHT; VKORC1; ANTICOAGULATION;
D O I
10.2217/PGS.15.87
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: To compare the accuracy of the nine selected algorithms for predicting warfarin dose with 586 Han Chinese patients. Materials & methods: Genotyping of VKORC1 1639G>A, CYP2C9*2 and CYP2C9*3 variants was performed. Both the mean absolute error and ideal estimation value were used for comparison. Results: The top three performers were from East Asians. The algorithms from Caucasians generally performed better in the medium-dose subgroup (>3 and <7 mg/day), while the algorithms from East Asians generally performed better in the low-dose subgroup (<= 3 mg/day). None of the algorithms performed well in the high-dose subgroup (>= 7 mg/day). Conclusion: Algorithms built for specific ethnic groups and p-reassigned-dose groups are suggested for better prediction.
引用
收藏
页码:1465 / 1474
页数:10
相关论文
共 50 条
  • [41] The study of warfarin maintenance dose algorithm in Chinese Han population
    Lou, Y.
    Liu, H.
    Han, L.
    Xie, S.
    Huang, Y. L.
    Li, Y. S.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S9 - S9
  • [42] Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
    Verhoef, Talitha I.
    Redekop, William K.
    Daly, Ann K.
    van Schie, Rianne M. F.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 626 - 641
  • [43] Failure of Pharmacogenetic-based Dosing Algorithms to Identify Older Patients Requiring Low Daily Doses of Warfarin
    Schwartz, Janice B.
    Kane, Lynn
    Wu, Alan H. B.
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2011, 12 (09) : 633 - 638
  • [44] Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients
    Xie, Cheng
    Xue, Ling
    Zhang, Yuzhen
    Zhu, Jianguo
    Zhou, Ling
    Hang, Yongfu
    Ding, Xiaoliang
    Jiang, Bin
    Miao, Liyan
    [J]. PHARMACOGENOMICS, 2020, 21 (01) : 23 - 32
  • [45] COMPARATIVE PERFORMANCE OF GENE-BASED WARFARIN DOSING ALGORITHMS IN CHINESE PATIENTS
    Yin, Tong
    Xu, Qiang
    Liu, Yu
    Wang, Hongjuan
    Yang, Jie
    Gao, Lei
    Zhang, Yuxiao
    Xu, Bin
    Lu, Caiyi
    Zhao, Yusheng
    Yin, Tong
    [J]. HEART, 2012, 98 : E128 - E129
  • [46] Pharmacogenetic dose adjustments in orthopedic patients beginning warfarin therapy
    Petra A. Jacobsen-Lenzini
    Charles S. Eby
    Paul E. Milligan
    Gloria R. Grice
    Elena Deych
    Leonard Grosso
    Eric Millican
    Susan K. Gatchel
    John C. Clohisy
    Robert L. Barrack
    Brian F. Gage
    [J]. Journal of Thrombosis and Thrombolysis, 2008, 25 : 100 - 100
  • [47] Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
    Marcela Galvez, Jubby
    Martin Restrepo, Carlos
    Constanza Contreras, Nora
    Alvarado, Clara
    Calderon-Ospina, Carlos-Alberto
    Pena, Nidia
    Cifuentes, Ricardo A.
    Duarte, Daniela
    Laissue, Paul
    Janeth Fonseca, Dora
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 : 169 - 178
  • [48] Evaluation of Pharmacogenetic Algorithm for Warfarin Dose Requirements in Japanese Patients
    Takeuchi, Fumihiko
    Kashida, Mitsuo
    Okazaki, Osamu
    Tanaka, Yuriko
    Fukuda, Shoji
    Kashima, Toshitaka
    Hosaka, Shigeru
    Hiroe, Michiaki
    Kimura, Sosuke
    Kato, Norihiro
    [J]. CIRCULATION JOURNAL, 2010, 74 (05) : 977 - 982
  • [49] Pharmacogenetic dose adjustments in orthopedic patients beginning warfarin therapy
    Jacobsen-Lenzini, Petra A.
    Eby, Charles S.
    Milligan, Paul E.
    Grice, Gloria R.
    Deych, Elena
    Grosso, Leonard
    Millican, Eric
    Gatchel, Susan K.
    Clohisy, John C.
    Barrack, Robert L.
    Gage, Brian F.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (01) : 100 - 100
  • [50] EFFECTS OF AFRICAN-SPECIFIC GENETIC VARIATION ON PERFORMANCE OF WARFARIN PHARMACOGENETIC DOSING ALGORITHMS
    Drozda, K.
    Wong, S.
    Patel, S.
    Nutescu, E.
    Cavallari, L. H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S11 - S11